...
首页> 外文期刊>Indian medical journal >Effectiveness of Albendazole in Improving Nutritional Status of Pre-School Children in Urban Slums of Darbhanga, Bihar
【24h】

Effectiveness of Albendazole in Improving Nutritional Status of Pre-School Children in Urban Slums of Darbhanga, Bihar

机译:阿苯达唑改善比哈尔邦达邦加贫民窟学龄前儿童营养状况的有效性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective : To study the clinical efficacy of albendazole in improving the nutritional status of pre-school children. Design : Single blind, placebo-controlled trial with child as the unit of randomization. Setting: In the Anganwadi centers of the Integrated Child Development Services situated in the urban slums of Darbhanga, Bihar. Subjects & Methods : Fifty Anganwadi centers were randomly selected for the trial. Included were registered resident children between 2 to 5 years of age with informed and written parental consent. The intervention group received 400 mg of albendazole powder every six months while the placebo group received same quantity of calcium powder. Enrolled children were contacted once in six months from )une2011 to May 2013 and given treatment. The outcome measure were change in the proportion of underweight (weight for age <-2.00z )and stunted (height for age <-2.00z) children. Results: There were 610 and 451 children in the albendazole and placebo groups, respectively. Mean age at recruitment was 31.8 months (SD: 9.7). Follow-up and compliance in both the groups was >95%. During the 2 year follow-up, the proportion of stunted children increased by 11.44% and 2.06% in the placebo and albendazole groups, respectively, and the difference was 9.38% (95% Cl 6.01% to 12.75%; p value <0.0001). Direct fecal smear was positive for the ova of ascaris in 41.2% and 55.3% children in the albendazole and placebo groups respectively at the end of the study (p value <0.001). Conclusions : Six monthly albendazole reduces the risk of stunting in pre-school children .
机译:目的:探讨阿苯达唑改善学龄前儿童营养状况的临床疗效。设计:以儿童为随机单位的单盲,安慰剂对照试验。地点:位于比哈尔邦达班加贫民窟的综合儿童发展服务的安加瓦第中心。受试者与方法:随机选择50个Anganwadi中心进行试验。其中包括经过知情和书面父母同意的2至5岁之间的登记常住儿童。干预组每六个月接受400毫克阿苯达唑粉,而安慰剂组接受相同量的钙粉。从2011年6月至2013年5月,每6个月对入组儿童进行一次接触并给予治疗。结果指标是体重不足(体重<-2.00z的体重)和发育不良(体重<-2.00z的身高)儿童比例的变化。结果:阿苯达唑和安慰剂组分别有610名儿童和451名儿童。招聘的平均年龄为31.8个月(标准差:9.7)。两组的随访和依从性均> 95%。在2年的随访中,安慰剂组和阿苯达唑组的发育不良儿童比例分别增加了11.44%和2.06%,差异为9.38%(95%Cl从6.01%至12.75%; p值<0.0001) 。在研究结束时,分别在阿苯达唑和安慰剂组中分别有41.2%和55.3%的儿童粪便直接涂片检出a虫卵(p值<0.001)。结论:六个月的阿苯达唑可降低学龄前儿童发育迟缓的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号